Biallelic TET2 mutations confer sensitivity to 5′-azacitidine in acute myeloid leukemiaFriedrich Stölzel, James M. Allan, Helen J. Blair et al.|JCI Insight|2022Cited by 9
Dual Bclxl and BCL2 Inhibition with Navitoclax (NAV), Venetoclax (VEN), and Decitabine (DEC) for Advanced Myeloid Neoplasms (MN): Safety and Biological Activity in a Phase 1 StudyEvan C. Chen, Jacqueline S. Garcia, Yiwen Liu et al.|Blood|2024Cited by 3